Opportunistic Salpingectomy for Preventing Ovarian Cancer

This trial explores whether removing the fallopian tubes (Bilateral Salpingectomy) during gallbladder surgery can help prevent ovarian cancer. This additional procedure could offer a safe and cost-effective way to reduce the risk of developing the most common and deadly type of ovarian cancer. The trial targets individuals with fallopian tubes undergoing gallbladder surgery, who have at least 24 hours between their surgeon consultation and the surgery, regardless of menopause status. Participants must be able to give informed consent and should not plan on becoming pregnant in the future. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research that could lead to new preventive strategies for ovarian cancer.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Research has shown that removing both fallopian tubes, a procedure called bilateral salpingectomy, is safe and generally well-tolerated. One study found that women who underwent this procedure did not experience significant negative effects on ovarian function. The surgery required only a few extra minutes, and no major complications were reported.

Researchers are excited about opportunistic salpingectomy as a preventative measure for ovarian cancer because it offers a novel approach to reducing cancer risk. Unlike traditional methods that typically involve monitoring or more invasive procedures like full oophorectomy, this technique involves the removal of the fallopian tubes (salpingectomy) during an unrelated surgery, such as a laparoscopic cholecystectomy. This method is minimally invasive and can be performed opportunistically during other routine surgeries, potentially offering a proactive and less disruptive option in preventing ovarian cancer. By targeting the fallopian tubes, where many ovarian cancers are believed to originate, this protocol could significantly reduce the risk with fewer side effects and less recovery time.

Research has shown that removing the fallopian tubes, a procedure called bilateral salpingectomy, can greatly reduce the risk of ovarian cancer. Studies have found that this surgery can lower the risk by up to 80%. It is particularly effective in preventing high-grade serous carcinoma, the most common and deadly type of ovarian cancer. Evidence indicates that this method is both safe and cost-effective. In this trial, some participants will undergo opportunistic salpingectomy in addition to laparoscopic cholecystectomy, while others will receive only the standard laparoscopic cholecystectomy. Even for women with an average risk of ovarian cancer, salpingectomy offers significant protective benefits.²³⁵⁶⁷